Teladoc Health (NYSE:TDOC) PT Lowered to $16.00

Teladoc Health (NYSE:TDOCGet Free Report) had its price objective reduced by JPMorgan Chase & Co. from $19.00 to $16.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “neutral” rating on the health services provider’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 34.23% from the stock’s previous close.

A number of other equities research analysts have also weighed in on TDOC. Canaccord Genuity Group reduced their target price on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Friday, April 26th. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a report on Thursday, February 29th. They set an “overweight” rating and a $22.00 target price on the stock. Royal Bank of Canada reduced their target price on shares of Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, April 26th. Stifel Nicolaus reduced their target price on shares of Teladoc Health from $21.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 26th. Finally, Bank of America reduced their price objective on shares of Teladoc Health from $16.50 to $13.50 and set a “neutral” rating on the stock in a research note on Tuesday, May 14th. Thirteen analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $18.22.

Get Our Latest Report on Teladoc Health

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $11.92 on Tuesday. The firm has a 50 day moving average of $13.73 and a 200-day moving average of $17.08. The stock has a market capitalization of $2.02 billion, a PE ratio of -8.45 and a beta of 0.97. The company has a current ratio of 3.82, a quick ratio of 3.74 and a debt-to-equity ratio of 0.67. Teladoc Health has a 12 month low of $11.67 and a 12 month high of $30.41.

Teladoc Health (NYSE:TDOCGet Free Report) last released its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The company had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. Teladoc Health’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.37) earnings per share. On average, equities research analysts predict that Teladoc Health will post -1.04 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the transaction, the insider now directly owns 86,070 shares of the company’s stock, valued at $1,092,228.30. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Teladoc Health news, insider Daniel Trencher sold 6,780 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $98,445.60. Following the transaction, the insider now owns 28,192 shares in the company, valued at $409,347.84. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Laizer Kornwasser sold 10,411 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the transaction, the insider now owns 86,070 shares in the company, valued at approximately $1,092,228.30. The disclosure for this sale can be found here. Insiders have sold a total of 137,368 shares of company stock valued at $1,968,587 over the last ninety days. 0.95% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of TDOC. ARK Investment Management LLC raised its holdings in shares of Teladoc Health by 4.5% in the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock valued at $457,389,000 after purchasing an additional 912,692 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Teladoc Health by 11.8% in the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after purchasing an additional 1,855,480 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Teladoc Health by 25.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock valued at $82,636,000 after purchasing an additional 767,999 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Teladoc Health by 6.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,654,116 shares of the health services provider’s stock valued at $35,646,000 after purchasing an additional 104,531 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. raised its holdings in shares of Teladoc Health by 9.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 658,435 shares of the health services provider’s stock valued at $12,240,000 after purchasing an additional 57,989 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Read More

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.